This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Problems related to care-provider dependency
Z21_PROBL_RELATED_CARE__DEPENDENCY
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
271 |
4. Check minimum number of eventsNone |
271 |
5. Include endpointsNone |
271 |
6. Filter based on genotype QC (FinnGen only) |
271 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z7
Similar endpoints
↥List of similar endpoints to
Problems related to care-provider dependency
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services in other circumstances, wide
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 271 | 111 | 160 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 75.45 | 74.76 | 75.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 239
- Matched controls
- 2390
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
+∞
95.3
85
*
Z74.2
ICD-10 Finland
Need for assistance at home and no other household member able to render care
+∞
57.6
53
*
Z74.1
ICD-10 Finland
Need for assistance with personal care
+∞
50.8
47
*
Z74.8
ICD-10 Finland
Other problems related to care-provider dependency
+∞
37.5
35
*
Z75.5
ICD-10 Finland
Holiday relief care
+∞
35.3
33
*
Z74.9
ICD-10 Finland
Problem related to care-provider dependency, unspecified
+∞
21.1
20
*
R51
NOMESCO Finland
Aids services
217.0
19.9
20
*
A29
ICPC
General symptom/complaint other
5.9
19.8
60
128
N05AX08
ATC
risperidone; systemic
5.2
17.5
59
141
N03AG01
ATC
valproic acid; systemic, rectal
7.9
15.9
37
54
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.2
14.3
47
108
A06AD11
ATC
lactulose; oral
3.3
14.0
88
361
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
13.0
113
568
F03
ICD-10 Finland
Unspecified dementia
4.5
12.7
48
127
N05AH04
ATC
quetiapine; oral
3.8
12.3
57
182
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
12.1
66
241
A28
ICPC
Limited function/disability NOS
3.2
11.8
74
297
N03AF01
ATC
carbamazepine; oral, rectal
6.0
11.5
32
60
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.2
11.3
66
251
WYA20
NOMESCO Finland
Home visit
12.0
11.3
20
18
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.4
11.1
29
50
N05BA04
ATC
oxazepam; oral
2.9
11.1
80
351
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.8
11.0
49
151
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.8
10.7
48
148
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.4
10.0
20
23
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.6
9.9
47
152
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.7
9.9
28
54
N05BA01
ATC
diazepam; systemic, rectal
3.5
9.8
47
154
N06AB04
ATC
citalopram; systemic
2.8
9.7
70
304
SPAT1262
SPAT
Handing over of treatment supplies
3.0
9.4
60
241
C03CA01
ATC
furosemide; systemic
2.4
9.3
127
776
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
38.2
9.1
11
*
N05AH03
ATC
olanzapine; systemic
5.8
9.0
25
47
R53
ICD-10 Finland
Malaise and fatigue
2.7
9.0
73
338
SPAT1229
SPAT
Assessment of need for aid
3.8
9.0
39
117
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.6
8.8
30
72
N03AE01
ATC
clonazepam; systemic
5.8
8.7
24
45
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
12.2
8.7
15
13
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.5
8.7
30
73
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.3
8.5
22
38
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
13.4
8.5
14
11
WW200
SPAT
NA
4.2
8.5
32
85
N03AX14
ATC
levetiracetam; systemic
11.3
8.4
15
14
N02AA05
ATC
oxycodone; systemic
2.9
8.3
56
231
CA1ME
NOMESCO Finland
Ultrasound oculometry
17.9
8.2
12
7
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
8.1
61
269
N05AA02
ATC
levomepromazine; systemic
5.9
7.9
21
38
K90
ICPC
Stroke/cerebrovascular accident
7.9
7.8
17
23
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
7.8
54
226
N05AD01
ATC
haloperidol; systemic
5.5
7.8
22
43
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
7.7
51
207
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
12.4
7.7
13
11
N30.0
ICD-10 Finland
Acute cystitis
2.9
7.5
46
179
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
8.8
7.4
15
18
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
9.8
7.4
14
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.9
7.3
23
51
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
5.6
7.3
20
38
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
7.1
96
564
WX704
NOMESCO Finland
Intubation
4.2
6.9
25
64
N03AX12
ATC
gabapentin; oral
3.1
6.9
39
143
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
6.8
91
527
K59.0
ICD-10 Finland
Constipation
4.2
6.8
25
65
WX892
NOMESCO Finland
Monitored bed care
3.7
6.7
28
82
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.6
6.7
29
88
M03BX01
ATC
baclofen; systemic
12.7
6.6
11
9
N05CD07
ATC
temazepam; oral
2.5
6.5
55
256
WZC00
SPAT
NA
5.5
6.5
18
35
Z75.0
ICD-10 Finland
Medical services not available in home
71.6
6.5
7
*
P29
ICPC
Psychological sympt/compl other
5.8
6.4
17
31
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.2
6.4
23
59
N06DX01
ATC
memantine; oral
2.8
6.4
41
164
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.3
105
661
A60
ICPC
General and Unspecified, Result test/procedure
4.7
6.3
20
45
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
4.1
6.3
23
60
Z74.3
ICD-10 Finland
Need for continuous supervision
+∞
6.3
6
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
8.0
6.2
13
17
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.4
6.2
55
263
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
6.2
71
385
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
13.0
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022621) pH of Urine by Test strip
81
124
8.89
53.97
7.9
3.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
59
137
5.23
24.87
6.9
6.7
mmol/l
25.3
24.2
1.11
59
127
(3002173) Hemoglobin [Mass/volume] in Arterial blood
68
178
4.76
24.84
6.4
7.7
g/l
120.8
121.0
0.03
68
171
(3019060) Gas panel - Arterial blood
59
146
4.89
22.98
6.5
4.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
69
199
4.31
22.08
7.1
7.3
%
95.9
95.7
0.15
69
190
(3019150) Specific gravity of Urine by Refractometry
104
403
3.56
21.67
8.6
4.9
kg/l
1.0
1.0
0.00
64
54
(3029937) Albumin [Presence] in Urine by Test strip
111
449
3.49
21.61
7.8
4.6
estimate
0.0
0.0
—
10
116
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
87
5.69
20.98
9.1
8.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
70
232
3.72
18.17
7.2
6.6
kpa
11.7
11.3
0.22
70
217
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
70
232
3.72
18.17
7.2
6.6
kpa
5.1
5.0
0.48
70
217
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
48
6.65
17.23
2.3
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
68
234
3.54
16.56
7.4
6.5
mmol/l
2.4
1.3
2.48
61
179
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
21
9.65
15.73
2.2
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
34
80
4.72
13.82
9.0
5.4
%
2.0
1.6
2.12
34
75
(3026008) Bacteria identified in Urine by Culture
114
616
2.47
11.54
6.3
3.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
116
638
2.43
11.23
8.6
4.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
135
801
2.37
10.93
8.0
4.3
estimate
0.0
0.0
0.00
11
114
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
10
11.42
10.22
2.6
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
132
793
2.30
10.18
9.6
5.8
estimate
0.0
0.0
—
10
120
(3035350) Ketones [Presence] in Urine by Test strip
132
795
2.29
10.10
8.1
4.3
estimate
0.0
0.0
0.00
11
122
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
141
3.15
9.11
2.2
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
84
437
2.34
8.87
9.0
3.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
59
4.17
8.34
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
98
570
2.13
7.72
6.0
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
243
2.47
7.30
2.3
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
20
52
4.07
7.12
12.6
2.8
mmol/l
25.4
24.3
0.40
20
42
(3044290) Cell count panel - Cerebral spinal fluid
12
20
6.23
6.96
2.6
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
68
378
2.07
5.83
3.9
2.9
mosm/kgh2o
560.2
556.3
0.04
41
314
(1616796) Gas panel - Central venous blood
15
41
3.81
5.00
3.4
3.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
96
2.77
4.88
2.5
3.3
%
0.5
1.0
1.01
13
41
(1761868) Lipid panel - Serum or Plasma
18
461
0.35
4.86
3.7
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
34
3.97
4.59
2.2
2.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
110
766
1.73
4.53
5.5
4.5
ng/l
62.4
46.7
0.26
92
575
(3042936) Bacteria identified in Isolate by Culture
46
245
2.06
4.36
3.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
43
238
1.96
3.66
1.7
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
69
444
1.74
3.65
2.0
1.8
nmol/l
1185.3
1126.0
0.31
58
325
(42870588) Differential panel, method unspecified - Blood
81
546
1.69
3.62
5.9
5.7
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
6
10.19
3.51
34.5
4.0
mmol/l
1.2
1.2
—
6
6
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
6
10.19
3.51
1.0
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
119
890
1.60
3.51
10.6
6.5
mmol/l
1.2
1.2
0.27
109
721
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
61
391
1.72
3.25
5.4
3.7
ng/l
74.7
233.6
1.63
49
343
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
241
1.88
3.22
1.9
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
14
50
2.90
3.13
5.3
2.5
kpa
8.4
8.1
0.18
14
44
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
8
7.64
3.07
1.2
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
54
340
1.73
3.06
2.1
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
148
1193
1.53
2.98
8.3
4.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
35
3.23
2.96
1.4
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
9
6.79
2.88
3.5
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
79
560
1.58
2.81
5.1
3.6
e6/l
80.7
170.7
0.33
73
447
(3023323) Follitropin [Units/volume] in Serum or Plasma
10
31
3.31
2.80
1.5
1.5
iu/l
16.1
22.0
—
10
25
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
126
2.08
2.76
1.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
47
300
1.69
2.53
4.3
4.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
22
3.71
2.38
1.6
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
102
790
1.47
2.35
20.0
10.7
inr
1.4
1.4
0.09
45
198
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
127
1519
0.69
2.34
4.3
4.5
mmol/l
1.3
1.4
2.41
122
1325
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
134
1587
0.69
2.33
4.7
5.0
mmol/l
2.4
2.5
0.82
128
1392
(3001604) Monocytes [#/volume] in Blood
102
791
1.46
2.33
6.2
5.2
e9/l
0.7
0.6
0.89
90
670
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
13
4.69
2.28
2.3
4.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
102
794
1.46
2.27
6.2
5.2
e9/l
0.0
0.0
0.05
91
679
(3018095) Leukocytes [#/volume] in Urine
85
639
1.48
2.26
5.8
3.9
e6/l
132.2
202.7
0.28
73
484
(36304419) Bacteria [Presence] in Urine
67
481
1.52
2.22
5.2
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
73
536
1.50
2.17
2.3
2.3
mg/l
2.7
3.2
0.99
67
453
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
14
4.36
2.16
2.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
34
208
1.73
2.14
1.5
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
71
520
1.50
2.13
2.5
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
130
1533
0.71
2.10
4.4
4.5
mmol/l
4.2
4.4
1.40
124
1358
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
85
648
1.45
2.09
5.1
3.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
74
550
1.48
2.06
6.2
3.8
ph
7.4
7.4
0.01
11
85
(3011288) Drugs identified in Urine by Screen method
6
15
4.07
2.05
2.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
21
3.39
1.98
2.9
3.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
45
2.51
1.95
1.4
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
122
1.87
1.90
14.3
3.6
mmol/l
3.7
2.2
0.97
13
94
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
52
0.00
1.90
0.0
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
79
2.09
1.89
1.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
66
2.18
1.85
5.4
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
12
4.22
1.83
1.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
23
3.10
1.81
1.3
1.9
%
91.4
88.3
—
7
23
(3013115) Eosinophils [#/volume] in Blood
102
823
1.38
1.78
6.6
5.6
e9/l
0.2
0.2
0.12
91
707
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
19
3.20
1.67
1.7
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
98
795
1.36
1.63
6.3
4.7
g/l
33.7
34.4
0.55
92
724
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
137
1562
0.75
1.54
4.7
4.7
mmol/l
6.3
6.1
0.88
131
1351
(3021589) Normoblasts [#/volume] in Blood
50
666
0.69
1.53
15.7
9.8
e9/l
0.0
0.0
0.47
43
535
(4094501)
0
44
0.00
1.52
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
27
2.63
1.52
1.6
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
27
2.63
1.52
1.6
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
374
1.45
1.51
6.0
4.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
28
2.54
1.46
1.6
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
28
2.54
1.46
1.6
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
16
3.16
1.44
1.2
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
91
743
1.34
1.43
5.4
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
81
1.90
1.43
3.3
3.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
24
2.53
1.31
9.2
3.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
34
2.39
1.30
1.6
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
97
811
1.31
1.27
6.3
5.3
e9/l
1.8
1.8
0.17
88
704
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
70
1.90
1.26
1.6
3.0
g/l
14.2
10.0
—
6
56
(40760888) Immunoglobulin light chains.free panel - Serum
8
36
2.26
1.25
1.3
5.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
19
2.66
1.22
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
142
1.60
1.18
1.6
1.4
—
—
—
0
0
(3013512) EKG study
39
519
0.71
1.18
4.3
4.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
395
0.68
1.16
2.3
3.1
ug/l
0.8
0.8
0.04
23
269
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
20
2.53
1.15
2.2
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
73
1.82
1.13
1.6
3.0
g/l
3.6
3.7
—
5
51
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
73
1.82
1.13
1.6
3.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
73
1.82
1.13
1.6
3.0
g/l
7.6
7.5
—
5
54
(3012516) Albumin [Mass/volume] in Urine
62
495
1.33
1.12
2.8
3.0
mg/l
2855.7
187.5
1.21
52
327
(3003694) ABO and Rh group [Type] in Blood
49
378
1.36
1.11
1.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
21
137
1.58
1.09
1.9
2.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
16
97
1.69
1.09
1.4
3.3
g/l
10.8
9.7
0.60
16
85
(3044941) Cell count panel - Synovial fluid
5
22
2.30
1.04
1.8
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
173
1.49
1.02
4.6
3.9
—
—
—
0
0
(4035726)
7
133
0.51
1.02
1.1
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
69
1.77
0.98
1.7
3.1
g/l
3.4
3.1
—
5
52
(40768793) Breast Pathology biopsy report
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
25
175
1.47
0.97
2.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
125
1.56
0.97
1.4
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
107
934
1.24
0.95
13.4
8.4
e9/l
5.3
4.4
1.71
97
807
(3027944) Amphetamines [Presence] in Urine
6
28
2.17
0.92
1.7
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
144
1311
1.21
0.82
42.3
20.3
%
14.4
13.9
3.59
144
1270
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
25
0.00
0.79
0.0
1.9
—
18.8
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
141
1.45
0.77
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
38
1.86
0.74
1.6
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
26
1.94
0.71
1.6
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
118
0.58
0.69
3.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.8
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
93
0.53
0.68
13.2
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
43
1.64
0.67
2.3
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
28
1.80
0.66
1.0
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94
836
1.19
0.66
2.4
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
178
1672
1.19
0.66
32.0
16.4
mg/l
33.9
28.6
1.23
168
1344
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
130
0.60
0.65
1.5
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
42
506
0.80
0.64
6.5
3.5
e6/l
0.6
0.5
0.19
36
398
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
49
1.65
0.62
4.1
5.5
mg/l
2.1
1.8
—
8
40
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
105
1.45
0.61
2.8
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
21
158
1.36
0.59
7.0
7.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
35
1.73
0.58
1.2
1.2
—
3.6
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
90
0.55
0.56
2.2
1.4
—
—
—
0
0
(3000492) Spirometry study
8
124
0.63
0.56
1.6
1.5
—
—
—
0
0
(3012544) pH of Venous blood
24
187
1.31
0.55
5.5
5.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
38
1.59
0.54
2.3
6.5
—
—
—
0
0
(3019225) pH of Specimen
12
169
0.70
0.54
3.2
3.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
50
431
1.20
0.50
2.4
2.9
umol/l
10630.8
12661.9
0.07
45
358
(3000330) Specific gravity of Urine by Test strip
7
106
0.65
0.49
6.6
4.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
7
45
1.57
0.49
1.3
1.2
mmol/l
62.0
61.6
—
7
36
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
142
1508
0.88
0.47
6.8
6.3
mmol/mol
43.6
41.2
1.61
137
1354
(3002256) Pathology report gross observation
16
209
0.75
0.47
1.6
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
82
0.60
0.46
13.0
4.0
mmol/l
24.3
25.6
—
5
77
(3044889) 12 lead EKG panel
124
1156
1.13
0.45
3.8
4.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
33
1.52
0.41
1.2
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
3.1
3.4
nmol/l
0.9
0.8
—
8
42
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
396
0.84
0.39
2.3
2.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
35
1.44
0.39
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
134
1.29
0.38
4.2
3.8
ml/min/173m2
42.3
55.8
—
7
61
(3009542) Hematocrit [Volume Fraction] of Blood
156
1486
1.12
0.37
38.7
17.9
%
35.6
38.5
1.41
54
931
(3034770) Mitochondria Ab [Titer] in Serum
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
166
1731
0.89
0.37
13.9
10.1
u/l
23.8
23.6
0.05
161
1637
(3020891) Body temperature
11
81
1.37
0.37
3.6
4.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
42
1.44
0.36
1.3
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
36
412
0.85
0.35
7.0
6.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
86
0.69
0.33
2.0
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
19
155
1.24
0.33
1.7
2.3
ug/g
101.0
135.7
0.28
14
124
(3020682) Albumin/Creatinine [Ratio] in Urine
58
525
1.13
0.33
3.3
3.8
mg/mmol
17.0
11.1
0.51
36
341
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
211
1.20
0.33
2.5
4.2
ug/l
6.0
60.3
0.85
17
180
(3052851) Hemolysis interference index of Serum or Plasma
6
47
1.28
0.32
4.5
3.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
142
0.77
0.31
8.5
3.9
—
—
—
0
0
(3010421) pH of Blood
7
52
1.36
0.31
8.3
2.8
ph
7.4
7.4
—
7
44
(3021960) Folate [Moles/volume] in Serum or Plasma
52
470
1.13
0.30
1.8
1.7
nmol/l
18.2
20.4
0.46
47
375
(3045414) Leukocytes [Presence] in Urine
8
62
1.30
0.28
3.0
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
67
621
1.10
0.26
2.6
2.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
33
294
1.14
0.24
3.8
2.3
g/l
2.4
2.2
0.51
33
261
(3022145) Colonoscopy Study observation
20
172
1.18
0.23
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
79
1.28
0.22
1.6
1.2
u/ml
249.3
217.7
—
10
73
(40761511) CBC panel - Blood by Automated count
176
1712
1.08
0.22
34.6
16.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.0
—
110.3
—
0
11
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.4
—
229.5
—
0
11
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
278.8
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
36.6
—
0
5
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
404.7
—
0
6
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(4306422)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
123
1182
1.07
0.21
4.6
3.5
pmol/l
14.7
15.1
1.03
114
1012
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
13
0.00
0.21
0.0
2.3
—
373.5
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
51
1.18
0.19
1.3
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
21
186
1.14
0.17
4.2
5.1
mmol/l
0.6
1.6
0.57
16
135
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
10
82
1.23
0.17
1.5
1.1
iu/ml
171.8
109.9
—
5
32
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
274
1.11
0.16
4.7
3.2
e6/l
1.3
1.9
0.33
16
162
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
153
1491
1.06
0.16
31.8
15.4
ml/min/173m2
67.7
72.8
1.10
109
1203
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
144
1478
0.95
0.15
5.6
4.3
mu/l
2.0
2.0
0.00
135
1261
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
188
1.13
0.15
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
127
1239
1.05
0.12
4.8
3.8
mm/h
18.1
14.5
1.24
121
1101
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
193
1.10
0.10
6.2
3.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
44
1.14
0.10
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
44
1.14
0.10
1.6
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
76
784
0.96
0.09
2.1
2.1
pmol/l
86.9
88.3
0.11
49
407
(42529406) Shigella sp [Presence] in Stool by Culture
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(4034850)
7
64
1.10
0.08
6.3
12.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
11
98
1.13
0.08
10.5
8.6
mmol/l
25.6
24.5
0.64
11
84
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
24
225
1.07
0.07
1.2
1.2
iu/ml
10.3
37.7
—
10
70
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
74
0.81
0.07
1.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
32
304
1.06
0.07
22.4
29.9
inr
2.0
1.3
2.29
12
28
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
245
1.07
0.07
10.1
9.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
78
1.03
0.07
1.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
97
949
1.03
0.07
3.5
3.1
u/l
47.2
54.3
0.40
87
865
(3021440) Promyelocytes/100 leukocytes in Blood
10
89
1.13
0.07
3.9
3.3
%
0.0
0.1
—
5
37
(4010399)
14
129
1.09
0.05
1.7
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
29
277
1.05
0.05
4.3
2.4
%
22.3
20.9
0.21
20
229
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
11
120
0.91
0.05
18.0
4.0
mmol/l
1.2
1.2
1.08
11
102
(3007164) IgA [Mass/volume] in Serum or Plasma
26
269
0.96
0.02
1.3
1.4
g/l
2.3
2.6
0.49
18
136
(3010813) Leukocytes [#/volume] in Blood
181
1821
0.98
0.02
43.5
23.8
e9/l
7.5
7.0
1.98
172
1740
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
570
1.02
0.02
4.3
4.9
%
22.6
21.9
0.15
31
296
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
32
311
1.03
0.02
1.4
1.2
u/ml
1.0
2.3
—
7
76
(3026361) Erythrocytes [#/volume] in Blood
181
1820
0.98
0.02
43.4
23.8
e12/l
4.2
4.4
3.80
173
1741
(3000963) Hemoglobin [Mass/volume] in Blood
181
1820
0.98
0.02
43.9
24.0
g/l
126.1
132.5
6.40
172
1768
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
183
1.04
0.01
2.0
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
306
0.98
0.00
4.4
3.0
e6/l
1.0
1.5
0.72
16
192
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
36
359
1.00
0.00
1.5
1.8
mg/l
1.3
1.4
0.05
26
292
(36660697) Celiac disease serology panel - Serum
10
105
0.95
0.00
1.1
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
5.6
—
103.9
—
0
7
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
77
0.91
0.00
1.4
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
73
0.96
0.00
3.4
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
56
0.89
0.00
2.0
3.5
g/l
0.0
0.0
—
5
47
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
101.2
—
0
9
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
2.9
—
1906.3
—
0
8
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
69
1.01
0.00
1.9
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
2.4
—
13.5
—
0
7
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
6.8
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
53
0.94
0.00
2.0
3.7
g/l
0.0
0.0
—
5
46
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.1
—
2.8
—
0
8
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
82
0.97
0.00
3.5
1.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.4
—
117.4
—
0
5
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
11.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
57
0.87
0.00
2.0
3.5
g/l
0.0
0.0
—
5
48
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
3.6
—
0
5
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.1
—
0
6
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROBL_RELATED_CARE__DEPENDENCY – Problems related to care-provider dependency
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).